Erich Zeisl

Title: The Innovations of Erich Zeisl

Introduction

Erich Zeisl is a notable inventor based in Jenbach, Austria. He has made significant contributions to the field of veterinary medicine, particularly through his innovative approaches to treating bacterial diseases in non-human animals. With a total of four patents to his name, Zeisl's work has had a meaningful impact on animal health.

Latest Patents

One of Zeisl's latest patents is titled "Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases." This patent describes a method for transdermally controlling bacterial infections in non-human animals. The method involves the topical application of a medicament containing valnemulin in either its free base or a pharmaceutically acceptable salt form. Another significant patent is "Agglomerates of β-lactam antibiotics and processes for making agglomerates." This patent focuses on agglomerates of β-lactam antibiotics, such as penicillin V potassium, amoxicillin trihydrate, and cephalexin monohydrate, which are suitable for direct tablet formation.

Career Highlights

Throughout his career, Erich Zeisl has worked with prominent companies in the pharmaceutical industry. He has been associated with Biochemie Gesellschaft M.b.H and Novartis Animal Health US, Inc. His work in these organizations has allowed him to develop and refine his innovative ideas in veterinary medicine.

Collaborations

Zeisl has collaborated with several professionals in his field, including Paul Howard Ripley and Johannes Raneburger. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Erich Zeisl's contributions to veterinary medicine through his innovative patents demonstrate his commitment to improving animal health. His work continues to influence the field and showcases the importance of innovation in addressing medical challenges.